🇺🇸 FDA
Patent

US 8815558

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

granted A61KA61K38/47

Quick answer

US patent 8815558 (Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof) held by HALOZYME, INC. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/47